ALKS vs CI · P/E 14, rev $1.56B vs P/E 2.4, rev $274.90B
Alkermes Plc (ALKS) versus Cigna Corp (CI) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
Cigna Corp (CI) is a healthcare plans company listed on US.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Not investment advice. Open the ALKS and CI stock pages for the full models.
Not investment advice.